CEL-SCI Corp (CVM)
0.60
0.00 (0.00%)
USD |
NYAM |
Nov 22, 09:31
CEL-SCI Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2011 | 0.5506 |
| June 30, 2011 | 0.5367 |
| March 31, 2011 | 0.1037 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.0396 |
| June 30, 2010 | 0.0318 |
| March 31, 2010 | 0.0319 |
| December 31, 2009 | 0.0328 |
| September 30, 2009 | 0.1253 |
| June 30, 2009 | 0.0972 |
| March 31, 2009 | 0.0577 |
| December 31, 2008 | 0.0098 |
| September 30, 2008 | 0.0185 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.0588 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.0012 |
| December 31, 2005 | 0.0005 |
| September 30, 2005 | 0.0014 |
| Date | Value |
|---|---|
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| September 30, 2004 | 0.0007 |
| June 30, 2004 | 0.00 |
| March 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| September 30, 2003 | 0.7128 |
| June 30, 2003 | 0.7699 |
| March 31, 2003 | 1.375 |
| December 31, 2002 | 1.274 |
| September 30, 2002 | 1.670 |
| June 30, 2002 | 0.8149 |
| March 31, 2002 | 0.5828 |
| December 31, 2001 | 0.3701 |
| September 30, 2001 | 0.00 |
| June 30, 2001 | 0.00 |
| March 31, 2001 | 0.0036 |
| December 31, 2000 | 0.0024 |
| September 30, 2000 | 0.0019 |
| June 30, 2000 | 0.00 |
| March 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| September 30, 1999 | 0.00 |
| June 30, 1999 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.9382 |
| IGC Pharma Inc | 0.0183 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Protalix BioTherapeutics Inc | 0.00 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 24.07M |
| Total Liabilities (Quarterly) | 15.60M |
| Shareholders Equity (Quarterly) | 8.473M |